Adherence to oral chemotherapy medications among gastroenterological cancer patients visiting an outpatient clinic

被引:18
作者
Hirao, Chieko [1 ]
Mikoshiba, Naoko [1 ]
Shibuta, Tomomi [1 ]
Yamahana, Reiko [1 ]
Kawakami, Aki [1 ]
Tateishi, Ryosuke [2 ]
Yamaguchi, Hironori [3 ]
Koike, Kazuhiko [2 ]
Yamamoto-Mitani, Noriko [1 ]
机构
[1] Univ Tokyo, Grad Sch Med, Div Hlth Sci & Nursing, Dept Gerontol Home Care & Long Term Care Nursing, Tokyo, Japan
[2] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
[3] Jichi Med Univ, Dept Clin Oncol, Shimotsuke, Tochigi, Japan
关键词
gastroenterological cancer; medication adherence; oral chemotherapy medications; outpatients; ANTINEOPLASTIC AGENTS; THERAPY; NONADHERENCE; DETERMINANTS; MORTALITY; COHORT; WOMEN;
D O I
10.1093/jjco/hyx087
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The purpose of this study was to investigate medication adherence to oral chemotherapy medications and determinants of medication non-adherence to them among gastroenterological cancer patients. Methods: A cross-sectional study was conducted on 117 consecutive, consenting, eligible patients visiting an outpatient clinic of university hospital in Japan. Good medication adherence was defined as taking 100% of the prescribed dose. Medication adherence was measured via self-report. We hypothesized that there was a significant relationship between medication non-adherence and the five factors defined by the World Health Organization: patient-related, socioeconomic-related, condition-related, treatment-related, and healthcare-system/provider-related factors. Multiple logistic regression models were used to identify factors associated with oral chemotherapy medication non-adherence. Results: The proportion of patients showing good medication adherence was 56.4%. The multiple logistic regression analysis revealed that the determinants of medication non-adherence to oral chemotherapy medications included having a history of patient-caused treatment interruptions due to worsening of symptoms (adjusted odds ratio [AOR] = 9.59, 95% confidence interval [CI] = 1.38-66.47), having diarrhea (AOR = 3.25, 95% CI = 1.13-9.34), experiencing pain (AOR = 0.17, 95% CI = 0.05-0.55), taking oral chemotherapy medication every 8 h (AOR = 5.52, 95% CI = 1.71-17.81), and diminished sense of priority for medication (AOR = 1.40, 95% CI = 1.21-1.63). Conclusions: This study suggests that many patients with gastroenterological cancer were non-adherent to oral chemotherapy medications. It might be necessary to conduct periodic screening and connect patients at a high risk of medication non-adherence to appropriate support.
引用
收藏
页码:786 / 794
页数:9
相关论文
共 50 条
  • [21] A smartphone program to support adherence to oral chemotherapy in people with cancer: Proof-of-concept trial
    Ross, Xiomara Skrabal
    Gunn, Kate M.
    Suppiah, Vijayaprakash
    Patterson, Pandora
    Boyle, Terry
    Carrington, Christine
    Tan, Shir Ley
    Ryan, Marissa
    Joshi, Rohit
    Olver, Ian
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 (05) : E378 - E387
  • [22] Adherence to cardiovascular disease risk factor medications among patients with cancer: a systematic review
    Leah L. Zullig
    Connor Drake
    Mohammad Shahsahebi
    Renee A. V. Avecilla
    Colette Whitney
    Coleman Mills
    Kevin C. Oeffinger
    Journal of Cancer Survivorship, 2023, 17 : 595 - 618
  • [23] Adherence to cardiovascular disease risk factor medications among patients with cancer: a systematic review
    Zullig, Leah L.
    Drake, Connor
    Shahsahebi, Mohammad
    Avecilla, Renee A. V.
    Whitney, Colette
    Mills, Coleman
    Oeffinger, Kevin C.
    JOURNAL OF CANCER SURVIVORSHIP, 2023, 17 (03) : 595 - 618
  • [24] Adherence to antihypertensive medications among family practice patients with diabetes mellitus and hypertension
    Natarajan, Nandini
    Putnam, Wayne
    Van Aarsen, Kristine
    Lawson, Beverley
    Burge, Fred
    CANADIAN FAMILY PHYSICIAN, 2013, 59 (02) : E93 - E100
  • [25] Adherence to Antihypertensive Medications and Cardiovascular Morbidity Among Newly Diagnosed Hypertensive Patients
    Mazzaglia, Giampiero
    Ambrosioni, Ettore
    Alacqua, Marianna
    Filippi, Alessandro
    Sessa, Emiliano
    Immordino, Vincenzo
    Borghi, Claudio
    Brignoli, Ovidio
    Caputi, Achille P.
    Cricelli, Claudio
    Mantovani, Lorenzo G.
    CIRCULATION, 2009, 120 (16) : 1598 - U82
  • [26] Medications Adherence and Associated Factors among Patients with Type 2 Diabetes Mellitus in the Gaza Strip, Palestine
    Elsous, Aymen
    Radwan, Mahmoud
    Al-Sharif, Hasnaa
    Abu Mustafa, Ayman
    FRONTIERS IN ENDOCRINOLOGY, 2017, 8
  • [27] A review on adherence management in patients on oral cancer therapies
    Wood, Leslie
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2012, 16 (04) : 432 - 438
  • [28] Adherence to Oral Administration of Endocrine Treatment in Patients With Breast Cancer: A Qualitative Study
    Iacorossi, Laura
    Gambalunga, Francesca
    Fabi, Alessandra
    Giannarelli, Diana
    Marchetti, Anna
    Piredda, Michela
    De Marinis, Maria Grazia
    CANCER NURSING, 2018, 41 (01) : E57 - E63
  • [29] A Structured Nursing Intervention to Address Oral Chemotherapy Adherence in Patients With Non-Small Cell Lung Cancer
    Boucher, Jean
    Lucca, Joan
    Hooper, Catherine
    Pedulla, Lillian
    Berry, Donna L.
    ONCOLOGY NURSING FORUM, 2015, 42 (04) : 383 - 389
  • [30] Oral Cancer Chemotherapy Adherence and Adherence Assessment Tools: a Report from North Central Cancer Group Trial N0747 and a Systematic Review of the Literature
    Patel, Krishna
    Foster, Nathan R.
    Farrell, Ann
    Le-Lindqwister, Nguyet Anh
    Mathew, Josy
    Costello, Brian
    Reynolds, John
    Meyers, Jeffrey P.
    Jatoi, Aminah
    JOURNAL OF CANCER EDUCATION, 2013, 28 (04) : 770 - 776